Nicotinell Spearmint (Nicotine Polacrilex)

Nicotine polacrilex, the active ingredient in Nicotinell Spearmint, is a nicotine replacement therapy presented as an oromucosal delivery system for use in the oral cavity. It is used to help adult smokers reduce nicotine withdrawal symptoms and cravings when they are trying to quit smoking.\n\nGNH India supplies Nicotinell Spearmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Spearmint is a nicotine replacement therapy that addresses nicotine dependence and supports quitting smoking.\n\n- Smoking cessation: helps reduce withdrawal symptoms and cravings in adult smokers attempting to quit.\n- Relapse prevention: supports maintaining abstinence after initial quitting.\n- Adjunct to behavioral therapy: enhances success when combined with counseling or support programs.

Nicotinell Spearmint may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Mouth irritation or soreness\n- Hiccups\n- Nausea\n- Headache\n- Dizziness\n- Unpleasant taste\n\nSerious or Rare Side Effects:\n- Throat swelling or difficulty breathing\n- Allergic reaction (rash, itching, swelling)\n- Severe nausea or vomiting\n- Chest pain or palpitations\n- Oral ulceration\n- Persistent dizziness or fainting

Before using Nicotinell Spearmint, consider the following safety points.\n\n- Cardiovascular assessment: patients with recent heart attack should consult a physician.\n- Hypertension monitoring: avoid use in uncontrolled high blood pressure.\n- Concomitant nicotine products: do not use with other nicotine replacement therapies to prevent overdose.\n- Pregnancy and breastfeeding: discuss risks with a healthcare professional before use.\n- Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotinell Spearmint can interact with other medicines; awareness helps prevent complications.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.\n- Other nicotine replacement products: risk of nicotine toxicity.\n- Certain antidepressants (e.g., bupropion): may raise seizure risk.\n\nModerate Interactions (Monitor Closely):\n- Caffeine: may enhance jitteriness or palpitations.\n- Alcohol: may increase nicotine cravings.\n- Antihypertensive agents: nicotine may reduce their effectiveness.